IEG Senior Epidemiologist – Cardiovascular Marketed & Late Phase Assets (all genders)

  • Full Time
  • Reading
  • Posted 2 months ago

Bayer

Job title:

IEG Senior Epidemiologist – Cardiovascular Marketed & Late Phase Assets (all genders)

Company

Bayer

Job description

At Bayer we’re visionaries, driven to solve the world’s toughest challenges and striving for a world where ,Health for all, Hunger for none’ is no longer a dream, but a real possibility. We’re doing it with energy, curiosity and sheer dedication, always learning from unique perspectives of those around us, expanding our thinking, growing our capabilities and redefining ‘impossible’. There are so many reasons to join us. If you’re hungry to build a varied and meaningful career in a community of brilliant and diverse minds to make a real difference, there’s only one choice.IEG Senior Epidemiologist – Cardiovascular Marketed & Late Phase Assets (all genders)Integrated Evidence Generation (IEG) has shown real impact on value- creation at scale across the pharma value chain. Bayer has made IEG a priority by exerting greater emphasis on real-world data (RWD) / real- world evidence (RWE) and has adapted its operating model to ensure integration across functions, geographies, methods/data types, most critically across the life cycle. The IEG TA is primarily responsible for shaping and integrating the execution of IEG plans across cardiovascular indications, functional needs and countries.YOUR TASKS AND RESPONSIBILITIES

  • Contribute to the definition of relevant research questions according to the IEG plan applicable for/addressable by observational studies, addressing business challenges identified by IEG TA heads or IEG Leads or IEG core teams/evidence generation teams
  • Design and execution of observational studies in close collaboration with cross-functional groups. The focus is on conducting effectiveness/safety and comparative effectiveness (CES) and safety studies for Kerendia as in market brand in CKD and as launch asset in Heart Failure, and for Acoramidis as launch asset in ATTR_Cardiomyopathy (CM)
  • Identify epidemiology methods, relevant data sources and assess utility/suitability for observational studies in collaboration with methodological experts and internal customer functions
  • Provide epidemiological perspectives, expertise, and recommendations in identification and design of observational studies, hybrid (interventional/non interventional) studies such as pragmatic trials, studies incorporating multiple data sources linkages and digital tools, patient preferences, sophisticated analytics, etc.
  • Serve as Bayer’s internal expert (all genders) on epidemiological topics to address needs from a broad customer base, including but not limited to Research, Clinical Development, Regulatory Affairs, PV, Medical Affairs, Market Access, and Commercial
  • Provide input on epidemiological activities/studies relevant to benefit risk management plans (RMP), clinical development submissions, other drug development and regulatory-related activities
  • Work with a high caliber advisory board for RWE and liaise with the FDA on selected Real World innovation topics
  • Contribute to IEG Partnerships initiatives for the identification and establishment of appropriate external research/methods groups/data sources, ensuring IEG needs are met
  • Contribute to scientific publications and presentations of epidemiological observational research activities and studies
  • Promote scientific collaborations with experts from academia and database owners; contribute to the intellectual leadership of Bayer in epidemiology
  • Present and communicate study plans and results to appropriate audiences

WHO YOU ARE

  • A Medical degree and/or a Life Sciences degree with a post-graduate qualification in Epidemiology (MSc, MPH or PhD) or a Life Science degree with a PhD in Epidemiology
  • Several years of Epidemiology and Pharmacoepidemiology experience, including some of that experience in industry or a regulatory agency (e.g., EMA or FDA) or in a public health/academic institution with strong links to industry; experience in Cardiovascular, Metabolic and/or Kidney/Renal diseases is a plus
  • Application of in-depth medical knowledge and expertise in the design, initiation and conduct of methodologically ambitious epidemiological studies including data platform studies, comparative studies, and/or post-launch safety studies for medical benefit-risk assessments
  • Demonstrable ability to design, direct and complete epidemiological observational research projects is required
  • Strong analytical skills and ability to apply statistical and epidemiological methodology in research projects
  • Understanding of risk management strategies and risk minimization programs ยท
  • Background in studying chronic diseases and special interest in utilizing database technology in the area of epidemiology is an advantage
  • Familiarity in the use of key source or harmonized US/EU medical and claims databases
  • Practical experience with the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) according to the OHDSI approaches is a plus
  • Very good interpersonal and communication skills as well as ‘soft leadership skills’ that facilitate cross-functional buy-in and engagement
  • Strong oral and written skills, including presentations and publications in English and local language

WHAT WE OFFERBe You at Bayer where you have the opportunity to be part of a culture influencing Health for all and Hunger for none.To achieve our vision we see reward for all our employees as incredibly important, so here are some benefits you will receive as a Bayer employee.

  • Competitive compensation package consisting of an attractive base salary and annual bonus
  • 28 days annual leave plus bank holidays
  • Private Healthcare, generous pension scheme and Life Insurance
  • Wellness programs and support
  • Employee discount scheme
  • State of the art offices
  • International career possibilities
  • Flexible and Hybrid working
  • Help with home office equipment
  • Volunteering days
  • Support of professional growth in a wide range of learning and development opportunities
  • We welcome and embrace diversity providing and inclusive working environment.

The best possible work-life balance is of great importance to us, which is why we support flexible hybrid working model. The position can in large part be carried out in the home office with occasional trips to one of our locations in Europe or on-site at one of our locations in Europe as Berlin, Wuppertal or London/Reading.You will find an open, team-oriented, innovative work culture and flat hierarchies here. We value a culture in which different personalities are valued and celebrated. We support the development and a self-caring lifestyle of our employees. Personal responsibility is at the heart of Dynamic Shared Ownership, our new organizational model. Our goal: 95% of decisions are made by those who do the work.#LI-DE#LI-UK#HybridLocation:United Kingdom : Berkshire : Reading || Germany : Berlin : Berlin || Germany : North Rhine Westfalia : Wuppertal-Aprath || Germany : North Rhine Westfalia : Wuppertal-ElberfeldDivision:PharmaceuticalsReference Code:821460

Expected salary

Location

Reading

Job date

Thu, 11 Jul 2024 04:07:18 GMT

To help us track our recruitment effort, please indicate in your email/cover letter where (globalvacancies.org) you saw this job posting.

To apply for this job please visit jobviewtrack.com.

Job Location